Literature DB >> 20302901

Impaired MMN/P3a complex in first-episode psychosis: cognitive and psychosocial associations.

Daniel F Hermens1, Philip B Ward, M Antoinette Redoblado Hodge, Manreena Kaur, Sharon L Naismith, Ian B Hickie.   

Abstract

Mismatch negativity (MMN) is a neurophysiological indicator of the brain's ability to extract relevant information from an irrelevant background. The P3a orienting response often accompanies MMN in deviance detection paradigms. Both MMN and P3a have been described as reliable biomarkers of schizophrenia. MMN/P3a impairments are associated with deficits in verbal memory and attentional switching, reflecting dysfunctions in the temporal and frontal systems, respectively. It remains unresolved whether MMN/P3a are robust biomarkers of psychosis in first-episode patients. Thirty-four young people (18 to 30years) were assessed in this study; 17 first-episode psychosis (FEP) patients were compared to 17 healthy controls. To elicit MMN/P3a, a two-tone passive auditory oddball paradigm with 8% duration deviants was used; event-related potentials were recorded at frontal, central and temporal (mastoid) sites. Neuropsychological assessments included processing speed, attentional switching, simple attention, and verbal learning and memory. Social functioning and quality of life measures were also obtained. The FEP group showed significantly reduced MMN amplitudes compared to controls. The FEP group also showed significantly reduced P3a amplitudes at frontal and central sites compared with controls. As expected, the FEP group also showed significant deficits in attention and verbal learning/memory. Correlational analyses found strong associations between fronto-central MMN/P3a peak amplitude and cognitive/psychosocial functioning. This study provides evidence of early neurobiological markers in young people with FEP. These findings suggest that MMN/P3a impairments are present at early stages of psychosis and that fundamental pre-attentive/deviance detection deficits may mark the beginning of progressive underlying changes with illness onset. Such deficits in FEP appear to have important links with higher-order cognitive and psychosocial functioning. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20302901     DOI: 10.1016/j.pnpbp.2010.03.019

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  62 in total

1.  Delayed preattentional functioning in early psychosis patients with cannabis use.

Authors:  Nicole Pesa; Daniel F Hermens; Robert A Battisti; Manreena Kaur; Ian B Hickie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2012-03-09       Impact factor: 4.530

Review 2.  Anticipating the future: automatic prediction failures in schizophrenia.

Authors:  Judith M Ford; Daniel H Mathalon
Journal:  Int J Psychophysiol       Date:  2011-09-28       Impact factor: 2.997

3.  Clinical significance of auditory target P300 subcomponents in psychosis: Differential diagnosis, symptom profiles, and course.

Authors:  Greg Perlman; Dan Foti; Felicia Jackson; Roman Kotov; Eduardo Constantino; Greg Hajcak
Journal:  Schizophr Res       Date:  2015-04-29       Impact factor: 4.939

Review 4.  Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function.

Authors:  Joshua T Kantrowitz; Neal R Swerdlow; Walter Dunn; Sophia Vinogradov
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2018-02-22

5.  Automatic sensory information processing abnormalities across the illness course of schizophrenia.

Authors:  C Jahshan; K S Cadenhead; A J Rissling; K Kirihara; D L Braff; G A Light
Journal:  Psychol Med       Date:  2011-07-11       Impact factor: 7.723

6.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Authors:  Micah A Shelton; Jason T Newman; Hong Gu; Allan R Sampson; Kenneth N Fish; Matthew L MacDonald; Caitlin E Moyer; James V DiBitetto; Karl-Anton Dorph-Petersen; Peter Penzes; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

7.  Decreased entropy modulation of EEG response to novelty and relevance in schizophrenia during a P300 task.

Authors:  Alejandro Bachiller; Alba Lubeiro; Álvaro Díez; Vanessa Suazo; Cristina Domínguez; José A Blanco; Marta Ayuso; Roberto Hornero; Jesús Poza; Vicente Molina
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-28       Impact factor: 5.270

8.  Neurophysiological biomarkers informing the clinical neuroscience of schizophrenia: mismatch negativity and prepulse inhibition of startle.

Authors:  Gregory A Light; Neal R Swerdlow
Journal:  Curr Top Behav Neurosci       Date:  2014

9.  Using biomarkers to inform diagnosis, guide treatments and track response to interventions in psychotic illnesses.

Authors:  Veronica B Perez; Neal R Swerdlow; David L Braff; Risto Näätänen; Gregory A Light
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

10.  Demand and modality of directed attention modulate "pre-attentive" sensory processes in schizophrenia patients and nonpsychiatric controls.

Authors:  Anthony J Rissling; Sung-Hyouk Park; Jared W Young; Michelle B Rissling; Catherine A Sugar; Joyce Sprock; Daniel J Mathias; Marlena Pela; Richard F Sharp; David L Braff; Gregory A Light
Journal:  Schizophr Res       Date:  2013-03-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.